-
-
-
-
-
-
-
Adamis Pharmaceuticals Announces Third Quarter 2019 Financial Results and Business Update
-
-
-
-
-
-
-
Adamis Pharmaceuticals Announces Conditional Acceptance by FDA of Proprietary Name for Higher Dose Naloxone Product
-
-
15,650 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

